Quarterly Report

Tempest Therapeutics, Inc. Filed 2018-05-03 Acc 0001544227-18-000004

Documents 1

2018-08-09 10-Q Quarterly Report
2018-05-03 10-Q Quarterly Report
2018-05-03 SC 13D/A Beneficial Ownership Report
2018-05-03 8-K Results of operations · Exit or restructuring costs · Delisting notice · Executive or director change · Other events
2018-04-30 DEFA14A Proxy Materials
2018-04-30 DEF 14A Proxy Statement
2017-11-02 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading ovas-20180331x10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…